Adenovirus vector bearing the CFTR gene: Began a Phase I safety trial in up to 26 patients, using repeated dosing in the large airways of the lung. The trial is

GenVec, Rockville, Md.

Read the full 46 word article

How to gain access

Continue reading with a
two-week free trial.